Literature DB >> 12851395

Akt signaling regulates side population cell phenotype via Bcrp1 translocation.

Masaki Mogi1, Jiang Yang, Jean-Francois Lambert, Gerald A Colvin, Ichiro Shiojima, Carsten Skurk, Ross Summer, Alan Fine, Peter J Quesenberry, Kenneth Walsh.   

Abstract

Akt is an important regulator of cell survival, growth, and glucose metabolism in many cell types, but the role of this signaling molecule in hematopoietic stem cells is poorly defined. Side population (SP) cells are enriched for hematopoietic stem cell activity and are defined by their ability to efficiently efflux Hoechst 33342. Bone marrow from Akt1-null mice exhibited a reduced SP fraction. However, bone marrow cellularity, growth factor-responsive progenitor cultures, and engraftable stem cells were normal in these mice. Treatment of bone marrow with LY294002, an inhibitor of the Akt effector protein phosphatidylinositol 3-kinase, led to a reversible loss of the SP fraction. Bcrp1, which encodes the Hoechst dye transporter, was translocated from the membrane to the intracellular compartment under conditions that promote the SP-depleted state. Lentivirus-mediated overexpression of Akt1 in bone marrow markedly increased the SP fraction, whereas there was no effect on bone marrow from Bcrp(-/-) mice. These data suggest that Akt signaling modulates the SP cell phenotype by regulating the expression of Bcrp1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12851395     DOI: 10.1074/jbc.M306362200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

1.  A high-content assay strategy for the identification and profiling of ABCG2 modulators in live cells.

Authors:  Christophe Antczak; Boyoung Wee; Constantin Radu; Bhavneet Bhinder; Eric C Holland; Hakim Djaballah
Journal:  Assay Drug Dev Technol       Date:  2013-08-30       Impact factor: 1.738

2.  Glutathione transport is a unique function of the ATP-binding cassette protein ABCG2.

Authors:  Heather M Brechbuhl; Neal Gould; Remy Kachadourian; Wayne R Riekhof; Dennis R Voelker; Brian J Day
Journal:  J Biol Chem       Date:  2010-03-23       Impact factor: 5.157

3.  Impaired angiogenesis in glutathione peroxidase-1-deficient mice is associated with endothelial progenitor cell dysfunction.

Authors:  Gennaro Galasso; Stephan Schiekofer; Kaori Sato; Rei Shibata; Diane E Handy; Noriyuki Ouchi; Jane A Leopold; Joseph Loscalzo; Kenneth Walsh
Journal:  Circ Res       Date:  2005-12-22       Impact factor: 17.367

4.  Targeting the ABCG2-overexpressing multidrug resistant (MDR) cancer cells by PPARγ agonists.

Authors:  Kenneth K W To; Brian Tomlinson
Journal:  Br J Pharmacol       Date:  2013-11       Impact factor: 8.739

5.  AKT1 and AKT2 maintain hematopoietic stem cell function by regulating reactive oxygen species.

Authors:  Marisa M Juntilla; Vineet D Patil; Marco Calamito; Rohan P Joshi; Morris J Birnbaum; Gary A Koretzky
Journal:  Blood       Date:  2010-03-30       Impact factor: 22.113

6.  Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay.

Authors:  Yimao Zhang; Youngjoo Byun; Yunzhao R Ren; Jun O Liu; John Laterra; Martin G Pomper
Journal:  Cancer Res       Date:  2009-06-30       Impact factor: 12.701

7.  Overexpression of ABCB1 and ABCG2 contributes to reduced efficacy of the PI3K/mTOR inhibitor samotolisib (LY3023414) in cancer cell lines.

Authors:  Chung-Pu Wu; Cheng-Yu Hung; Sabrina Lusvarghi; Yang-Hui Huang; Pin-Jung Tseng; Tai-Ho Hung; Jau-Song Yu; Suresh V Ambudkar
Journal:  Biochem Pharmacol       Date:  2020-07-04       Impact factor: 5.858

8.  Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway.

Authors:  P-P Liu; J Liao; Z-J Tang; W-J Wu; J Yang; Z-L Zeng; Y Hu; P Wang; H-Q Ju; R-H Xu; P Huang
Journal:  Cell Death Differ       Date:  2013-10-04       Impact factor: 15.828

9.  ARRY-334543 reverses multidrug resistance by antagonizing the activity of ATP-binding cassette subfamily G member 2.

Authors:  De-Shen Wang; Atish Patel; Hong-May Sim; Yun-Kai Zhang; Yi-Jun Wang; Rishil J Kathawala; Hui Zhang; Tanaji T Talele; Suresh V Ambudkar; Rui-Hua Xu; Zhe-Sheng Chen
Journal:  J Cell Biochem       Date:  2014-08       Impact factor: 4.429

10.  Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478.

Authors:  Zhi Shi; Amit K Tiwari; Suneet Shukla; Robert W Robey; In-Wha Kim; Smitaben Parmar; Susan E Bates; Qiu-Sheng Si; Curtis S Goldblatt; Ioana Abraham; Li-Wu Fu; Suresh V Ambudkar; Zhe-Sheng Chen
Journal:  Biochem Pharmacol       Date:  2008-11-18       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.